Submissions from 2020
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children., Leonardo R Brandão, Manuela Albisetti, Jacqueline Halton, Lisa Bomgaars, Elizabeth Chalmers, Lesley G Mitchell, Ildar Nurmeev, Pavel Svirin, Tomas Kuhn, Ondrej Zapletal, Igor Tartakovsky, Monika Simetzberger, Fenglei Huang, Zhichao Sun, Jörg Kreuzer, Savion Gropper, Martina Brueckmann, Matteo Luciani, DIVERSITY Study Investigators, and Judy Felgenhauer (DIVERSITY Study Investigator)
A phase II trial evaluating the efficacy of high-dose Radioiodinated Tositumomab (Anti-CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high-risk relapsed or refractory non-hodgkin lymphoma., Victor A Chow, Joseph G Rajendran, Darrell R Fisher, Frederick R Appelbaum, Ryan D Cassaday, Paul S Martin, Leona A Holmberg, Theodore A Gooley, Philip A Stevenson, John M Pagel, Damian J Green, Oliver W Press, and Ajay K Gopal
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study., Antonio Cuneo; Anthony R Mato; Gian Matteo Rigolin; Alfonso Piciocchi; Massimo Gentile; Luca Laurenti; John N Allan; John M Pagel; Danielle M Brander; Brian T Hill; Allison Winter; Nicole Lamanna; Constantine S Tam; Ryan Jacobs; Frederick Lansigan; Paul M Barr; Mazyar Shadman; Alan P Skarbnik; Jeffrey J Pu; Alison R Sehgal; Stephen J Schuster; Nirav N Shah; Chaitra S Ujjani; Lindsey Roeker; Ester Maria Orlandi; Atto Billio; Livio Trentin; Martin Spacek; Monia Marchetti; Alessandra Tedeschi; Fiorella Ilariucci; Gianluca Gaidano; Michael Doubek; Lucia Farina; Stefano Molica; Francesco Di Raimondo; Marta Coscia; Francesca Romana Mauro; Javier de la Serna; Angeles Medina Perez; Isacco Ferrarini; Giuseppe Cimino; Maurizio Cavallari; Rosalba Cucci; Marco Vignetti; Robin Foà; Paolo Ghia; and GIMEMA, European Research Initiative (ERIC) on CLL, US study group
The Efficacy of Passive Valve Antimicrobial Swab Caps Against Existing Clabsi Prevention Bundle in an Adult Hematology Inpatient Population: A Quality Improvement Initiative, Joseph F. Ferry, Neil Bailey, Vanessa Dunleavy, Joanna Fesler, Judson Hall, Sonia Glennie, William Bensinger, Raya Mawad, Krish Patel, Daniel N Egan, John M Pagel, and Livia Hegerova
The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma., Nathan H Fowler, Loretta Nastoupil, Sven De Vos, Mark Knapp, Ian W Flinn, Robert Chen, Ranjana H Advani, Sumeet Bhatia, Peter Martin, Raul Mena, Richard Eric Davis, Sattva S Neelapu, Karl Eckert, Jerry Ping, Melannie Co, Darrin M Beaupre, Jutta K Neuenburg, and M Lia Palomba
Disparities in the Occurrence of Late Effects following Treatment among Adolescent and Young Adult Melanoma Survivors., Alicia A Gingrich, Candice A M Sauder, Melanie Goldfarb, Qian Li, Ted Wun, and Theresa H M Keegan
Blood test shows high accuracy in detecting stage I non-small cell lung cancer., Cherylle Goebel, Christopher L Louden, Robert McKenna, Osita Onugha, Andrew Wachtel, and Thomas Long
The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database., Beate Haeberle, Arun Rangaswami, Mark Krailo, Piotr Czauderna, Eiso Hiyama, Rudolf Maibach, Dolores Lopez-Terrada, Daniel C Aronson, Rita Alaggio, Marc Ansari, Marcio H Malogolowkin, Giorgio Perilongo, Allison F O'Neill, Angela Trobaugh-Lotrario, Kenichiro Watanabe, Irene Schmid, Dietrich von Schweinitz, Sarangarajan Ranganathan, Kenichi Yoshimura, Tomoro Hishiki, Yukichi Tanaka, Jin Piao, Yurong Feng, Eugenia Rinaldi, Davide Saraceno, Marisa Derosa, and Rebecka L Meyers
Allogeneic autophagosome-enriched composition for the treatment of disease, Traci Hilton, Sandra Aung, Rieneke van de Ven, Christopher Paustian, Tarsem Moudgil, Christopher Dubay, Christopher Twitty, Hong-Ming Hu, and Bernard A Fox
Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders., Henry G Kaplan, Gregory S Calip, and Judith A Malmgren
Management of CLL Patients Early in the COVID-19 Pandemic: An International Survey of CLL Experts, Brian Koffman, Anthony Mato, John C. Byrd, Alexey Danilov, Brad Hedrick, Chaitra Ujjani, Lindsey Roeker, Deborah M. Stephens, Matthew S. Davids, John M Pagel, and Mazyar Shadman
Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome., Je-Hwan Lee, Stefan Faderl, John M Pagel, Chul Won Jung, Sung-Soo Yoon, Animesh D Pardanani, Pamela S Becker, Howard Lee, Jeongeun Choi, Kyoungjune Lee, Minkyoung Kim, and Jorge E Cortes
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies., Manuela Cristina Matesan, Darrell R Fisher, Roger Wong, Ajay K Gopal, Damian J Green, William Bensinger, Brenda Sandmaier, John Pagel, Johnnie Orozco, Oliver W Press, Ryan Cassaday, Michele Wanner, Eric Hutchinson, Sujit Pal, Carolyn Thostenton, and Joseph Rajendran
Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL Registry., Anthony R Mato, Jacqueline C Barrientos, Nilanjan Ghosh, John M Pagel, Danielle M Brander, Meghan Gutierrez, Karen Kadish, Brian Tomlinson, Reethi Iyengar, David Ipe, Sandhya Upasani, Carlos I Amaya-Chanaga, Murali Sundaram, Jennifer Han, Nick Giafis, and Jeff P Sharman
Phase 2 Study of the Safety and Efficacy of Umbralisib in Patients with CLL Who Are Intolerant to BTK or PI3Kδ Inhibitor Therapy., Anthony R Mato, Nilanjan Ghosh, Stephen J Schuster, Nicole Lamanna, John M Pagel, Ian W Flinn, Jacqueline Barrientos, Kanti R Rai, James A Reeves, Bruce D Cheson, Paul M Barr, Suman Kambhampati, Frederick Lansigan, Jeffrey J Pu, Alan P Skarbnik, Lindsey Elizabeth Roeker, Gustavo Fonseca, Andrea Sitlinger, Issam S Hamadeh, Colleen Dorsey, Nicole LaRatta, Hanna Weissbrot, Eline T Luning Prak, Patricia Y Tsao, Dana Paskalis, Peter Sportelli, Hari P Miskin, Michael S Weiss, Jakub Svoboda, and Danielle M Brander
Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience., Anthony R Mato, Lindsey Elizabeth Roeker, Nicole Lamanna, John Allan, Lori Ann Leslie, John M Pagel, Krish Patel, Anders Osterborg, Daniel Wojenski, Manali Kamdar, Scott F Huntington, Matthew S Davids, Jennifer R Brown, Darko Antic, Ryan W Jacobs, Inhye E Ahn, Jeffrey J Pu, Krista Isaac, Paul M Barr, Chaitra Ujjani, Mark Blaine Geyer, Ellin Berman, Andrew D Zelenetz, Nikita Malakhov, Richard R Furman, Michael Koropsak, Neil Bailey, Lotta Hansson, Guilherme Fleury Perini, Shuo Ma, Christine E Ryan, Adrian Wiestner, Craig A Portell, Mazyar Shadman, Elise A Chong, Danielle M Brander, Suchitra Sundaram, Amanda N Seddon, Erlene Seymour, Meera Patel, Nicolas Martinez-Calle, Talha Munir, Renata Walewska, Angus Broom, Harriet Sarah Walter, Dima El-Sharkawi, Helen Parry, Matthew R Wilson, Piers E Patten, José-Ángel Hernández-Rivas, Fatima Miras, Noemi Fernández Escalada, Paola Ghione, Chadi Nabhan, Sonia Lebowitz, Erica B Bhavsar, Javier López-Jiménez, Daniel Naya, Jose Antonio Garcia-Marco, Sigrid S Skånland, Raul Cordoba, and Toby Andrew Eyre
Fertility Concerns and Access to Care for Stem Cell Transplant Candidates with Sickle Cell Disease., Adrienne D Mishkin, Markus Y Mapara, Michelle Barhaghi, and Ran Reshef
A Phase 2, Open-Label, Multicenter Study of Tazemetostat in Combination with Rituximab for the Treatment of Relapsed or Refractory Follicular Lymphoma, Krish Patel, Neil Bailey, and John M Pagel
Real World Observational Study Using Clonoseq® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry, Krish Patel, Neil Bailey, John M Pagel, and See all authors in comments
Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306)., Ruth Pettengell, Monika Długosz-Danecka, David Andorsky, David Belada, Pencho Georgiev, Donald Quick, Jack W Singer, Simran B Singh, Athanasios Pallis, Anton Egorov, and Gilles Salles
Worldwide Examination of Patients with CLL Hospitalized for COVID-19, Lindsey E. Roeker, Neil Bailey, and See full list of authors in comments
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial., Jeff P Sharman, Miklos Egyed, Wojciech Jurczak, Alan Skarbnik, John M Pagel, Ian W Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Gillian Corbett, Laura Maria Fogliatto, Yair Herishanu, Versha Banerji, Steven Coutre, George Follows, Patricia Walker, Karin Karlsson, Paolo Ghia, Ann Janssens, Florence Cymbalista, Jennifer A Woyach, Gilles Salles, William G Wierda, Raquel Izumi, Veerendra Munugalavadla, Priti Patel, Min Hui Wang, Sofia Wong, and John C Byrd
A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia., Catherine C Smith, Mark J Levis, Olga Frankfurt, John M Pagel, Gail J Roboz, Richard M Stone, Eunice S Wang, Paul L Severson, Brian L West, Mai H Le, Sabine Kayser, Bao Lam, Henry H Hsu, Chao Zhang, Gideon Bollag, and Alexander E Perl
Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration., Deborah M Stephens, Ken Boucher, Elizabeth Kander, Sameer A Parikh, Erin M Parry, Mazyar Shadman, John M Pagel, Jennifer Cooperrider, Joanna Rhodes, Anthony Mato, Allison Winter, Brian Hill, Sameh Gaballa, Alexey Danilov, Tycel Phillips, Danielle M Brander, Sonali M Smith, Matthew Davids, Kerry Rogers, Martha J Glenn, and John C Byrd
Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma., Sherilyn A Tuazon, Ryan D Cassaday, Theodore A Gooley, Brenda M Sandmaier, Leona A Holmberg, Stephen D Smith, David G Maloney, Brian G Till, Daniel B Martin, Victor A Chow, Joseph G Rajendran, Darrell R Fisher, Manuela C Matesan, Sally J Lundberg, Damian J Green, John M Pagel, Oliver W Press, and Ajay K Gopal
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy., Chaitra Ujjani, Anthony Mato, Brian T Hill, John N Allan, Frederick Lansigan, Ryan Jacobs, Alan Skarbnik, Hande Tuncer, John M Pagel, Danielle Brander, Bruce Cheson, Paul Barr, Lindsey E Roeker, Jeffrey Pu, Nirav N Shah, Andre Goy, Stephen J Schuster, Nicole Lamanna, Alison Sehgal, Constantine S Tam, and Mazyar Shadman
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia., Geoffrey L Uy, Ibrahim Aldoss, Matthew C Foster, Peter H Sayre, Matthew J Wieduwilt, Anjali S Advani, John E Godwin, Martha L Arellano, Kendra Sweet, Ashkan Emadi, Farhad Ravandi, Harry P Erba, Michael Byrne, Laura C Michaelis, Max S Topp, Norbert Vey, Fabio Ciceri, Matteo Giovanni Carrabba, Stefania Paolini, Gerwin Huls, Mojca Jongen-Lavrencic, Martin Wermke, Patrice Chevallier, Emmanuel Gyan, Christian Récher, Patrick Stiff, Kristen Pettit, Bob Löwenberg, Sarah Church, Erica Katherine Anderson, Jayakumar Vadakekolathu, Marianne T Santaguida, Michael P Rettig, John Muth, Teia Curtis, Erin Fehr, Kuo Guo, Jian Zhao, Ouiam Bakkacha, Kenneth Jacobs, Kathy Tran, Patrick Kaminker, Maya Kostova, Ezio Bonvini, Roland B Walter, Jan Kenneth Davidson-Moncada, Sergio Rutella, and John F DiPersio
Advances in targeted therapy for acute myeloid leukemia., Jifeng Yu, Peter Y Z Jiang, Hao Sun, Xia Zhang, Zhongxing Jiang, Yingmei Li, and Yongping Song
Submissions from 2019
Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib., Farrukh T Awan, Anna Schuh, Jennifer R Brown, Richard R Furman, John M Pagel, Peter Hillmen, Deborah M Stephens, Jennifer Woyach, Elena Bibikova, Prista Charuworn, Melanie M Frigault, Ahmed Hamdy, Raquel Izumi, Bolan Linghu, Priti Patel, Min Hui Wang, and John C Byrd
Pituitary Apoplexy., Garni Barkhoudarian and Daniel F Kelly
Long-term follow-up of the RESONATE™ phase 3 trial of ibrutinib versus ofatumumab., John C Byrd, Peter Hillmen, Susan O'Brien, Jacqueline C Barrientos, Nishitha M Reddy, Steven Coutre, Constantine S Tam, Stephen P Mulligan, Ulrich Jaeger, Paul M Barr, Richard R Furman, Thomas J Kipps, Patrick Thornton, Carol Moreno, Marco Montillo, John M Pagel, Jan A Burger, Jennifer A Woyach, Sandra Dai, Remus Vezan, Danelle F James, and Jennifer R Brown
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results., John C Byrd, William George Wierda, Anna Schuh, Stephen Devereux, Jorge M Chaves, Jennifer R Brown, Peter Hillmen, Peter Martin, Farrukh T Awan, Deborah M Stephens, Paolo Ghia, Jacqueline Barrientos, John M Pagel, Jennifer A Woyach, Kathleen Burke, Todd Covey, Michael Gulrajani, Ahmed Hamdy, Raquel Izumi, Melanie M Frigault, Priti Patel, Wayne Rothbaum, Min Hui Wang, Susan O'Brien, and Richard R Furman
Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy., Victor A Chow, Ajay K Gopal, David G Maloney, Cameron J Turtle, Stephen D Smith, Chaitra S Ujjani, Mazyar Shadman, Ryan D Cassaday, Brian G Till, Yolanda D Tseng, Edus H Warren, Andrei R Shustov, Manoj P Menon, Sandra Bhark, Utkarsh H Acharya, Erin Mullane, Lindsay M Hannan, Jenna M Voutsinas, Ted A Gooley, and Ryan C Lynch
Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation., Jeffrey A Cohen, Laura E Baldassari, Harold L Atkins, J D Bowen, Christopher Bredeson, Paul A Carpenter, John R Corboy, Mark S Freedman, Linda M Griffith, Robert Lowsky, Navneet S Majhail, Paolo A Muraro, Richard A Nash, Marcelo C Pasquini, Stefanie Sarantopoulos, Bipin N Savani, Jan Storek, Keith M Sullivan, and George E Georges
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia., Toby A Eyre, Lindsey E Roeker, Christopher P Fox, Satyen H Gohill, Renata Walewska, Harriet S Walter, Francesco Forconi, Angus Broom, Arvind Arumainathan, Danielle M Brander, John N Allan, Stephen J Schuster, Brian T Hill, Frederick Lansigan, Bruce D Cheson, Nicole Lamanna, Catherine C Coombs, Paul M Barr, Alan P Skarbnik, Mazyar Shadman, Chaitra S Ujjani, Laurie Pearson, John M Pagel, Ryan Jacobs, and Anthony R Mato
Reversal of acquired von Willebrand syndrome with allogeneic stem cell transplant for chronic lymphocytic leukemia., Livia Hegerova, Fiona He, Nicole D Zantek, Gregory M Vercellotti, Shernan G Holtan, and Mark T Reding
Case report of two siblings with type 2A von Willebrand disease involving a novel mutation within the calcium-binding site of the A2 domain of von Willebrand factor., Henry P Igid, Kyaw Z Thein, Michael Castine, and Donald P Quick
Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data., Vera Ignjatovic, Philipp E Geyer, Krishnan K Palaniappan, Jessica E Chaaban, Gilbert S Omenn, Mark S Baker, Eric W Deutsch, and Jochen M Schwenk
Granulocyte Colony-Stimulating Factors in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia., Henry G Kaplan, Judith A Malmgren, and Gregory S Calip
ACG Clinical Guideline: Hereditary Hemochromatosis., Kris V Kowdley, Kyle E Brown, Joseph Ahn, and Vinay Sundaram
Surgical and anesthetic management for hepatectomy in two pediatric patients with trisomy 18, pulmonary hypertension, and hepatoblastoma., Donald J Lucas, Jeremy Rubinstein, Ankush Gosain, Greg Tiao, Tim Head, J Nick Pratap, Regan Williams, Sara Helmig, James Geller, Max Langham, and Angela Trobaugh-Lotrario
Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies, Anthony R. Mato, Neil Bailey, and See full list of authors in comments
A Phase Ib study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma., Joseph Mikhael, Paul Richardson, Saad Z Usmani, Noopur Raje, William Bensinger, Chatchada Karanes, Frank Campana, Dheepak Kanagavel, Franck Dubin, Qianying Liu, Dorothée Semiond, and Kenneth Anderson
Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: A clinical review., Vincent A Pallazola, Rishi K Kapoor, Karan Kapoor, John W McEvoy, Roger S Blumenthal, and Ty J Gluckman
Duvelisib for CLL/SLL and follicular non-Hodgkin lymphoma., Krish Patel, Alexey V Danilov, and John M Pagel
Exploring a Future for PI3K Inhibitors in Chronic Lymphocytic Leukemia., Krish Patel and John M Pagel
Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees., Krish Patel, Vinjamuri S Sudhir, Shaum Kabadi, Joanna C Huang, Sanchita Porwal, Kushan Thakkar, and John M Pagel
Apixaban-induced haematoma causing small bowel intussusception., Ariel P Santos, Jennifer M Rodriguez, and Grace Berry
ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL)., Jeff P Sharman, Versha Banerji, Laura Maria Fogliatto, Yair Herishanu, Talha Munir, Renata Walewska, George Follows, Karin Karlsson, Paolo Ghia, Gillian Corbett, Patricia Walker, Miklos Egyed, Wojciech Jurczak, Gilles Salles, Ann Janssens, Florence Cymbalista, William G Wierda, Steven Coutre, John M Pagel, Alan Skarbnik, Manali Kamdar, Jennifer Woyach, Raquel Izumi, Veerendra Munugalavadla, Priti Patel, Min Hui Wang, Sofia Wong, and John C Byrd
Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms., Jen-Chin Wang, Chi Chen, Ajay Kundra, Sreenath Kodali, Anita Pandey, Ching Wong, Tony Cheung, Vladimir Gotlieb, Gardith Joseph, and Sophia Tribie
Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients, Maryam Sarraf Yazdy, John M Pagel, Neil Bailey, Krish Patel, and See full list of authors in comments
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study., Habte Yimer, Jason Melear, Edward Faber, William Bensinger, John M Burke, Mohit Narang, Don Stevens, Sriya Gunawardena, Yana Lutska, Keqin Qi, Jon Ukropec, Ming Qi, Thomas S Lin, and Robert M Rifkin
Blood Is a Window into Health and Disease., James T Yurkovich and Leroy Hood
Submissions from 2018
Physical activity and epigenetic biomarkers in maternal blood during pregnancy., Sylvia E Badon, Alyson J Littman, Kwun Chuen Gary Chan, Mahlet G Tadesse, Patricia L Stapleton, Theo K Bammler, Tanya K Sorensen, Michelle A Williams, and Daniel A Enquobahrie
A Single Center Retrospective Study of Real World Relapsed/Refractory DLBCL Patients Eligible for CAR T-Cell Therapy: Patient Characteristics and Outcomes, Neil Bailey, John M Pagel, William Bensinger, Livia Hegerova, Raya Mawad, Michael Milder, Jennie Szeto, Ngan Trinh, Tenzin Tsomo, Paul Wisnewski, Clarisse M. Zayas, and Krish Patel
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)., John C Byrd, Amy S Ruppert, Nyla A Heerema, Alese E Halvorson, Eva Hoke, Mitchell R Smith, John E Godwin, Stephen Couban, Todd A Fehniger, Michael J Thirman, Martin S Tallman, Frederick R Appelbaum, Richard M Stone, Sue Robinson, Julie E Chang, Sumithra J Mandrekar, and Richard A Larson
Editorial Perspective., Jens R Chapman
Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression in Philadelphia Chromosome Negative Myeloid Neoplasms, Chi Chen, Anita Pandey, Ajay Kundra, Sreenath Kodali, Ching Wong, Tony W. Cheung, Vladimir K. Gotlieb, Gardith Joseph, Sophia Tribie, and Jen-Chin Wang
Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation., Livia Hegerova, Adam Bachan, Qing Cao, Huong X Vu, John Rogosheske, Mark T Reding, Claudio G Brunstein, Mukta Arora, Celalettin Ustun, Gregory M Vercellotti, and Veronika Bachanova
Mindfulness-Based Interventions for Hematology and Oncology Patients with Pain., Denise Hess
Venetoclax As Monotherapy or in Combination: Patterns of Use and Predictors of Outcomes in an International Multicenter Study of CLL Patients, Anthony R. Mato, John M Pagel, Neil Bailey, and See all authors in comments
Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial., Anthony R Mato, Lindsey E Roeker, John N Allan, John M Pagel, Danielle M Brander, Brian T Hill, Bruce D Cheson, Richard R Furman, Nicole Lamanna, Constantine S Tam, Sasanka Handunnetti, Ryan Jacobs, Frederick Lansigan, Erica Bhavsar, Paul M Barr, Mazyar Shadman, Alan P Skarbnik, Andre Goy, Douglas F Beach, Jakub Svoboda, Jeffrey J Pu, Alison R Sehgal, Clive S Zent, Hande H Tuncer, Stephen J Schuster, Peter V Pickens, Nirav N Shah, Joanna Rhodes, Chaitra S Ujjani, and Chadi Nabhan
Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials., Megan Othus, Elihu H Estey, Guillermo Garcia-Manero, Brent L Wood, Derek L Stirewalt, John E Godwin, James K Weick, Jeanne E Anderson, Frederick R Appelbaum, Harry P Erba, and Roland B Walter
Adverse Events, Patterns of Tumor Lysis Syndrome Prophylaxis and Management, and Dosing Patterns in a Large Cohort of Venetoclax Treated CLL Patients in Community and Academic Settings, Lindsey E. Roeker, Neil Bailey, and See full list of authors in comments
Submissions from 2017
Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease., John C Kash, Kathie-Anne Walters, Jason Kindrachuk, David Baxter, Kelsey Scherler, Krisztina B Janosko, Rick D Adams, Andrew S Herbert, Rebekah M James, Spencer W Stonier, Matthew J Memoli, John M Dye, Richard T Davey, Daniel S Chertow, and Jeffery K Taubenberger
A Journey of Educational Transformation and Organizational Improvement through Development of an Institutional Patient Blood Management Program, Robert Raggi, Karen Klein, Marci Swearingen, and Mark Domantay
Submissions from 2016
Navigating your career path in pediatric hematology/oncology: On and off the beaten track., Patrick A Zweidler-McKay, Mary-Jane Staba Hogan, Rima Jubran, Vandy Black, Jacqueline Casillas, James Harper, Suman Malempati, Judith Margolin, Judy Felgenhauer, Kathleen M Sakamoto, Janet Franklin, Mona Shah, Nita Seibel, George Buchanan, Sarah R Vaiselbuh, Caroline Hastings, Joanne Hilden, and Linda C Stork
